3 ms·
We could take a portion of those r&d incentives and directly test and compare the cost & output of government pharma research vs private research in a mixed mod
by Hammershaft 3y ago
We could take a portion of those r&d incentives and directly test and compare the cost & output of government pharma research vs private research in a mixed model.
- s1artibartfast 3y agoIt seems the prinicpal "R&D incentive" that the parent poster considered was IP/patent law. Im not sure how that baby could be split in an A/B test. Pharma companies receive very little (relatively) in terms of grants or research funding. R&D spending can be amortized as a business expense when calculating a tax bill, so I suppose that could be repealed, raising the effective tax rate.
- sudosysgen 3y agoPharma companies receive easy and extremely subsidized access to research that costs almost a hundred billion every year. They don't need to be the direct recipients of the grant to be the direct benefactors.